NASDAQ:CDLX - Cardlytics Stock Price, Forecast & News

Cardlytics' stock was trading at $45.83 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CDLX stock has decreased by 29.2% and is now trading at $32.47. View which stocks have been mosted impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Cardlytics.

Cardlytics is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Cardlytics.

Cardlytics Inc (NASDAQ:CDLX) posted its earnings results on Tuesday, March, 3rd. The company reported $0.18 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.04 by $0.14. The company had revenue of $69.29 million for the quarter, compared to analyst estimates of $69.19 million. Cardlytics had a negative net margin of 8.15% and a negative return on equity of 19.49%. The firm's revenue for the quarter was up 44.9% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.06) earnings per share. View Cardlytics' earnings history.

Cardlytics issued an update on its first quarter 2020 After-Hours earnings guidance on Tuesday, March, 3rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $43.5-46.5 million, compared to the consensus revenue estimate of $52.77 million.

7 equities research analysts have issued twelve-month price objectives for Cardlytics' shares. Their forecasts range from $26.00 to $100.00. On average, they anticipate Cardlytics' share price to reach $62.17 in the next twelve months. This suggests a possible upside of 91.5% from the stock's current price. View analysts' price targets for Cardlytics.

Headlines about CDLX stock have been trending very negative recently, InfoTrie reports. The research firm identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cardlytics earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutCardlytics.

Some companies that are related to Cardlytics include Livongo Health (LVGO), Medallia (MDLA), Tripadvisor (TRIP), DouYu International (DOYU), SVMK (SVMK), Sabre (SABR), 21Vianet Group (VNET), Pluralsight (PS), Internet Initiative Japan (IIJIY), Health Catalyst (HCAT), HealthStream (HSTM), Model N (MODN), Qutoutiao (QTT), Eventbrite (EB) and Phoenix Tree (LIZI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include Trade Desk (TTD), Alibaba Group (BABA), Caterpillar (CAT), Micron Technology (MU), Advanced Micro Devices (AMD), NVIDIA (NVDA), Square (SQ), Crispr Therapeutics (CRSP), Roku (ROKU) and Netflix (NFLX).

(CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."

Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CDLX stock can currently be purchased for approximately $32.47.

Cardlytics has a market capitalization of $741.29 million and generates $210.43 million in revenue each year. The company earns $-17,140,000.00 in net income (profit) each year or ($0.75) on an earnings per share basis.  View additional information about Cardlytics.

The official website for Cardlytics is http://www.cardlytics.com/.

Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected]